MedTrace Logo

CHANGE Feasibility Study

NCT02671032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-06-09

Study results available
· View outcomes & findings →

Summary

The purpose of the feasibility study is to examine audiological outcomes (audiometry and speech perception) and safety (adverse events and adverse device effects) with the Nucleus CI532 cochlear implant in group of adult subjects (n=12) who meet current criteria for cochlear implantation.

Conditions

Interventions

DEVICE

Nucleus CI532 cochlear implant

Sponsors & Collaborators

  • The Hearing Cooperative Research Centre

    collaborator OTHER

  • Royal Victoria Eye and Ear Hospital

    collaborator OTHER_GOV

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Robert Cowan, DipAud PhD · HEARing CRC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-05
Primary Completion
2019-07-15
Completion
2019-07-15

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671032 on ClinicalTrials.gov